Disposable Safety Lancets Companies and Market Forecast
The global disposable safety lancets market was estimated at US$ 625 million in 2023 and is projected to grow to US$ 1,142.86 million by 2034, rising at a compound annual growth rate (CAGR) of 5.64% from 2024 to 2034.
Top Companies in the Disposable Safety Lancets:
- Drawbridge Health
- Roche – Accu-Chek
- Becton Dickinson – Lancet Plus
- Ascensia
- Lifescan
- B. Braun
- Nipro Diagnostics – Sure-Lancet
- Cardinal Health
- ARKRAY
- Own Mumford – Unistik
- Dexcom
- Abbott
Latest Announcement by Industry Leaders
In April 2024, Jerome Scelza, Co-CEO of Drawbridge Health, expressed enthusiasm about Nanodrop and mentioned, “the company is continuing to build the ‘healthcare of tomorrow’ through unparalleled research and development, science and technology," Jerome further adds, “NanoDrop’s versatility, accuracy and ease of use make it an essential tool for healthcare professionals and consumers including in a decentralized clinical trial setting.”
Recent Developments
- In April 2024, Drawbridge Health, a pioneering healthcare technology company, announced its advanced at-home blood sampling device – NanoDrop lancet. The product has received US FDA approval for over-the-counter use.
- In March 2024, Roche announced its latest innovation in diabetes continuous glucose monitoring at the 17th International Conference on Advance Technology and Treatment for Diabetes in Florence, Italy. The new Accu-Chek SmartGuide solution for real-time diabetes management is built with predictive Artificial Intelligence.
If you have any questions, please feel free to contact us at
